Clinical Trial Update: Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold [NA]

View source ↗

Summary

This update reports the completion of the Safety & Performance Study of the FANTOM sirolimus-eluting bioresorbable coronary scaffold for coronary artery disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold (sirolimus-eluting bioresorbable scaffold)

Snippet

Sponsor: REVA Medical, Inc. | Conditions: Coronary Artery Disease | NA | Status: COMPLETED